UBA1 and VEXAS syndrome: These molecular insights provide a framework for studying regulatory principles of ubiquitylation at the E1-E2 level, for determining cellular downstream consequences of loss of UBA1 activity, and for developing therapeutic strategies to treat VEXAS syndrome and UBA1-related diseases in the future.